• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

3-羟基-4-喹诺酮类化合物的设计、合成及其抗增殖活性

王峰华, 王凯, 沈建华, 陈凯先

王峰华, 王凯, 沈建华, 陈凯先. 3-羟基-4-喹诺酮类化合物的设计、合成及其抗增殖活性[J]. 中国药科大学学报, 2014, 45(3): 286-292. DOI: 10.11665/j.issn.1000-5048.20140306
引用本文: 王峰华, 王凯, 沈建华, 陈凯先. 3-羟基-4-喹诺酮类化合物的设计、合成及其抗增殖活性[J]. 中国药科大学学报, 2014, 45(3): 286-292. DOI: 10.11665/j.issn.1000-5048.20140306
WANG Fenghua, WANG Kai, SHEN Jianhua, CHEN Kaixian. Design, synthesis and antiproliferative activity of 3-hydroxy-4-quinolone compounds[J]. Journal of China Pharmaceutical University, 2014, 45(3): 286-292. DOI: 10.11665/j.issn.1000-5048.20140306
Citation: WANG Fenghua, WANG Kai, SHEN Jianhua, CHEN Kaixian. Design, synthesis and antiproliferative activity of 3-hydroxy-4-quinolone compounds[J]. Journal of China Pharmaceutical University, 2014, 45(3): 286-292. DOI: 10.11665/j.issn.1000-5048.20140306

3-羟基-4-喹诺酮类化合物的设计、合成及其抗增殖活性

Design, synthesis and antiproliferative activity of 3-hydroxy-4-quinolone compounds

  • 摘要: 将二氢杨梅素和喹诺酮抗肿瘤化合物的结构特征拼合,设计了一系列3-羟基-4-喹诺酮类化合物;以3,5-二甲氧基苯胺为原料,经还原氨化、弗克酰基化、微波促进闭环、BBr3催化脱甲基、Mannich反应等步骤制备得到16个目标化合物;采用MTT法测定了化合物对肺肿瘤细胞株A549和NCI-H 460的增殖抑制活性。所合成的16个化合物均未见文献报道,其结构经IR、MS、1H NMR确证;活性测试结果显示,多个化合物对两种细胞株均表现出中等的抗增殖活性,化合物 11b 对NCI-H 46细胞的抑制作用最强。初步构效关系表明:在3-羟基-4-喹诺酮结构的N-1位进入异戊烯基能显著地提高化合物的抗肿瘤活性。
    Abstract: A combination of the structural features of dihydromyricetin and quinolone antineoplastic compounds gave rise to 3-hydroxy-4-quinolone motif. Starting from 3, 5-dimethoxyaniline, the target compounds were prepared through a reaction cascade, including reductive amination, Friedel-Crafts reaction, microwave assisted ring closure, BBr3 catalyzed demethylation and Mannich reaction. Sixteen novel compounds were synthesized, and their structures were confirmed by IR, MS and 1H NMR. The antiproliferative activities of the compounds against A549 and NCI-H 460 cells were tested in MTT assay. Several compounds exhibited moderate antiproliferative activities against both cell lines, of which, compound 11b displayed the most robust inhibition towards NCI-H 460. Preliminary structural-activity relationships indicated that introduction of isopentenyl into the N-1 position of 3-hydroxy-4-quinolone motif would significantly improve the potency of the compounds.
  • [1] Balderas R,Gonzalez BP,Garcia A,et al.Anticancer drug design using scaffolds of β-lactams,sulfonamides,quinoline,quinoxaline and natural products.Drugs advances in clinical trials[J]. Curr Med Chem,2012,19(26):4 377-4 398.
    [2] Liu EH,Qi LW,Wu Q,et al.Anticancer agents derived from natural products[J]. Mini Rev Med Chem,2009,9(13):1 547-1 555.
    [3] Ji WS,Li AL. Medicinal Chemistry(药物化学)[M].Beijing:High Education Press,1999:466-505.
    [4] Zeng S,Liu DU,Ye YL,et al.Anti-tumor efects of ampelopsin on human lung cancer GLC-82 implanted in nude mice[J]. J Chin Med Mate(中药材),2004,27(11):842-845.
    [5] Ohyama M,Tanaka T,Ito T,et al.Antitumor agents 200.Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives[J]. Bio Org Med Chem Lett,1999,9(20):3 057-3 060.
    [6] Liu DY,Luo M.Study on inhibitory effect of ampelopsin on melanoma by serologic pharmacological method[J]. J Chin Med Mate(中药材),2001,24(5):348-350.
    [7] Liu DY,Lei HQ.Inhibitory effects of myricetin and ampelopsin on tyrosinas[J]. Chin Biochem J(生物化学杂志),1996(5):618-620.
    [8] Zhou NN,Zhu XF,Xie BF,et al.Research on the antitumor effects of ampelopsin from Canton Ampelopsis Root[J]. Guangdong Pharm J(广东药学),2000,10(4):7-8.
    [9] Facchinetti V,Gomes CR,de Souza MV,et al.Perspectives on the development of novel potentially active quinolones against tuberculosis and cancer[J]. Mini Rev Med Chem,2012,12(9):866-874.
    [10] Xu QJ,Hou LL,Wu XK,et al.Synthesis and antitumor activity of ciprofloquinolone bis-(C3/C7 hydrazone)s[J].J China Pharm Univ(中国药科大学学报),2013,44(1):35-38.
    [11] Sissi C,Palumbo M.The quinolone family:from antibacterial to anticancer agents[J]. Curr Med Chem Anticancer Agents,2003,3(6):439-450.
    [12] Abbas JA,Stuart RK.Vosaroxin:a novel antineoplastic quinolone[J]. Expert Opin Investig Drugs,2012,21(8):1 223-1 233.
    [13] Chen JC,Huang CS,Liu HX,et al.Prenyl and geranyl favonoids compounds with biological activities[J]. Technol Dev Chem Ind(化工技术与开发),2013,42(1):12-17.
    [14] Sui ZH,Nguyen Van N,Altom J,et al.Synthesis and topoisomerase inhibitory activities of novel aza-analogues of flavones[J]. Eur J Med Chem,1999,34(5):381-387.
计量
  • 文章访问数:  1095
  • HTML全文浏览量:  3
  • PDF下载量:  1572
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭